{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:50:17Z","timestamp":1783993817803,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.01.024","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T05:32:00Z","timestamp":1359523920000},"page":"1892-1897","source":"Crossref","is-referenced-by-count":68,"title":["Chlamydia trachomatis control requires a vaccine"],"prefix":"10.1016","volume":"31","author":[{"given":"Robert C.","family":"Brunham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.01.024_bib0005","unstructured":"CDC Grand Rounds. Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep 2011 60(April (12)):370\u20133."},{"key":"10.1016\/j.vaccine.2013.01.024_bib0010","unstructured":"Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. World Health Organization 2001."},{"key":"10.1016\/j.vaccine.2013.01.024_bib0015","unstructured":"Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections \u2013 2002. MMWR Recomm Rep 2002;51(October (RR-15)):1\u201338; quiz CE1\u20134."},{"issue":"December (25)","key":"10.1016\/j.vaccine.2013.01.024_bib0020","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMcp030542","article-title":"Clinical practice. Genital chlamydial infections","volume":"349","author":"Peipert","year":"2003","journal-title":"N Engl J Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.01.024_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198407053110101","article-title":"Mucopurulent cervicitis \u2013 the ignored counterpart in women of urethritis in men","volume":"311","author":"Brunham","year":"1984","journal-title":"N Engl J Med"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/158.3.510","article-title":"Etiology and outcome of acute pelvic inflammatory disease","volume":"158","author":"Brunham","year":"1988","journal-title":"J Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/infdis\/152.6.1275","article-title":"Chlamydia trachomatis: its role in tubal infertility","volume":"152","author":"Brunham","year":"1985","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.01.024_bib0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00006250-198605000-00022","article-title":"Chlamydia trachomatis infection in women with ectopic pregnancy","volume":"67","author":"Brunham","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.01.024_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/sti.2007.027938","article-title":"Epidemiology of chlamydial infection: are we losing ground?","volume":"84","author":"Rekart","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2013.01.024_bib0050","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.01.024_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/OLQ.0b013e31815e41a3","article-title":"The arrested immunity hypothesis and the epidemiology of chlamydia control","volume":"35","author":"Brunham","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/315046","article-title":"The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection","volume":"180","author":"Su","year":"1999","journal-title":"J Infect Dis"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2013.01.024_bib0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1574-695X.2008.00509.x","article-title":"Considerations on Chlamydia trachomatis disease expression","volume":"55","author":"Brunham","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.01.024_bib0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/infdis\/jis644","article-title":"Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy","volume":"207","author":"Rekart","year":"2013","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.01.024_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/infdis\/173.4.950","article-title":"The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group","volume":"173","author":"Brunham","year":"1996","journal-title":"J Infect Dis"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0085","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/428287","article-title":"The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study","volume":"191","author":"Molano","year":"2005","journal-title":"J Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0090","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/173.6.1437","article-title":"Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya","volume":"173","author":"Kimani","year":"1996","journal-title":"J Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0095","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.39.3.1491-1494.1983","article-title":"Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix","volume":"39","author":"Brunham","year":"1983","journal-title":"Infect Immun"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/432070","article-title":"Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma","volume":"192","author":"Cohen","year":"2005","journal-title":"J Infect Dis"},{"issue":"January\u2013March (1)","key":"10.1016\/j.vaccine.2013.01.024_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007435-199101000-00005","article-title":"Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis","volume":"18","author":"Wolner-Hanssen","year":"1991","journal-title":"Sex Transm Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0110","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/IAI.65.6.2175-2182.1997","article-title":"Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring","volume":"65","author":"Van Voorhis","year":"1997","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0270","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0125","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/IAI.59.4.1346-1351.1991","article-title":"Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract","volume":"59","author":"Igietseme","year":"1991","journal-title":"Infect Immun"},{"issue":"February (4):","key":"10.1016\/j.vaccine.2013.01.024_bib0275","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.4049\/jimmunol.1102764","article-title":"Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract","volume":"188","author":"Johnson","year":"2012","journal-title":"J Immunol"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0135","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.161.3.1439","article-title":"Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection","volume":"161","author":"Yang","year":"1998","journal-title":"J Immunol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/605411","article-title":"Role of T lymphocytes in the pathogenesis of Chlamydia disease","volume":"200","author":"Igietseme","year":"2009","journal-title":"J Infect Dis"},{"issue":"July (Pt 7)","key":"10.1016\/j.vaccine.2013.01.024_bib0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1099\/jmm.0.05093-0","article-title":"Chlamydial vaccine development","volume":"52","author":"Longbottom","year":"2003","journal-title":"J Med Microbiol"},{"issue":"April\u2013June (2)","key":"10.1016\/j.vaccine.2013.01.024_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007435-197804000-00011","article-title":"The potential for vaccine against infection of the genital tract with Chlamydia trachomatis","volume":"5","author":"Grayston","year":"1978","journal-title":"Sex Transm Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.01.024_bib0280","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.ppat.1002344","article-title":"Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?","volume":"7","author":"Poland","year":"2011","journal-title":"PLoS Pathog"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0160","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/IAI.31.3.1161-1176.1981","article-title":"Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis","volume":"31","author":"Caldwell","year":"1981","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.01.024_bib0165","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.58.9.3101-3108.1990","article-title":"Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein","volume":"58","author":"Tan","year":"1990","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.01.024_bib0170","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1099\/00221287-139-12-2965","article-title":"Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis","volume":"139","author":"Batteiger","year":"1993","journal-title":"J Gen Microbiol"},{"issue":"July (8)","key":"10.1016\/j.vaccine.2013.01.024_bib0175","first-page":"1477","article-title":"A chlamydial major outer membrane protein extract as a trachoma vaccine candidate","volume":"36","author":"Campos","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.01.024_bib0180","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/IAI.65.8.3361-3369.1997","article-title":"Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge","volume":"65","author":"Pal","year":"1997","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.01.024_bib0185","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2013.01.024_bib0190","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2013.01.024_bib0285","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1073\/pnas.1101756108","article-title":"Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines","volume":"108","author":"Finco","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0290","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4049\/jimmunol.1001240","article-title":"A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans","volume":"185","author":"Wang","year":"2010","journal-title":"J Immunol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0205","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.180.4.2459","article-title":"Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia","volume":"180","author":"Karunakaran","year":"2008","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.01.024_bib0295","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.024_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/omi.1.1999.4.187","article-title":"Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae","volume":"4","author":"Grimwood","year":"1999","journal-title":"Microb Comp Genomics"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.01.024_bib0300","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00109-010-0600-y","article-title":"Autotransporter passenger proteins: virulence factors with common structural themes","volume":"88","author":"Nishimura","year":"2010","journal-title":"J Mol Med (Berl)"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2013.01.024_bib0225","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/JB.183.8.2686-2690.2001","article-title":"Characterization of outer membrane proteins in Chlamydia trachomatis LGV serovar L2","volume":"183","author":"Tanzer","year":"2001","journal-title":"J Bacteriol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2013.01.024_bib0305","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JB.01628-09","article-title":"Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics","volume":"192","author":"Liu","year":"2010","journal-title":"J Bacteriol"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0235","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.01.024_bib0240","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/IAI.01566-08","article-title":"Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family","volume":"77","author":"Tan","year":"2009","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.01.024_bib0310","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1462-5822.2009.01389.x","article-title":"Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis","volume":"12","author":"Tan","year":"2010","journal-title":"Cell Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.01.024_bib0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/JB.188.1.275-286.2006","article-title":"Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism","volume":"188","author":"Gomes","year":"2006","journal-title":"J Bacteriol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0255","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/IAI.71.3.1200-1208.2003","article-title":"Polymorphic membrane protein H has evolved in parallel with the three disease-causing groups of Chlamydia trachomatis","volume":"71","author":"Stothard","year":"2003","journal-title":"Infect Immun"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0260","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol"},{"issue":"October (11)","key":"10.1016\/j.vaccine.2013.01.024_bib0315","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates","volume":"208","author":"Kari","year":"2011","journal-title":"J Exp Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.01.024_bib0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2013.01.024_bib0325","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2011.11.036","article-title":"Bridging innate, adaptive immunity","volume":"147","author":"Paul","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2013.01.024_bib0330","doi-asserted-by":"crossref","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","volume":"7","author":"Berlanda Scorza","year":"2012","journal-title":"PLoS One"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.01.024_bib0335","doi-asserted-by":"crossref","first-page":"e1002258","DOI":"10.1371\/journal.ppat.1002258","article-title":"Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector","volume":"7","author":"Wang","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T01:33:44Z","timestamp":1688002424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13000819"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}